Compared with controls, miR-31 overexpression significantly suppressed Bach2 expression, while miR-31 inhibitor induced Bach2 expression in CD4+ T cells from CHD patients, both at mRNA and protein levels (Figure 4D). Here, BACH2 is linked to coronary artery disorder.